Normal donor T-cell responses to putative EphA2-derived peptide epitopes
Responder CD4+ or CD8+ T cells were analyzed for reactivity against the HLA-A2+/DR4+ target cell line T2.DR4 pulsed with no peptides, or pulsed with irrelevant or EphA2-derived peptides. T cell reactivity against T2.DR4 cells pulsed with the HLA-A2-presented HIV-nef190–198 epitope served as the CD8+ cell negative control, while HLA-DR4-presented Malarial circumsporozooite (CS)326–345 epitope served as the CD4+ T cell negative control. These control values were subtracted from experimental determinations in order to determine EphA2-specific T cell responder spot numbersa per 100,000 T cells, bA value of “0” reflects a frequency < 1/100,000 T cells. The appropriate HLA-A2 or −DR4 restricted nature of specific T cell recognition of peptides was validated by inclusion of anti-HLA-A2 or -DR4 mAb in replicate ELISPOT wells, respectively, with >90% inhibition of EphA2-specific recognition observed (data not shown). Values significantly (p < 0.05) elevated over T2.DR4+ control peptide values are italicized.
A. HLA-A2-presented EphA2 peptides . | . | . | . | . | . | |||||
---|---|---|---|---|---|---|---|---|---|---|
Normal donor # . | CD8+ T-cell response to peptide on T2.DR4a (IFN-γ spots/105 CD8+ T cells) . | . | . | . | . | |||||
. | 162 . | 391 . | 546 . | 883 . | 961 . | |||||
A2-1 | 9 | 0b | 31 | 0 | 2 | |||||
A2-2 | 40 | 81 | 14 | 85 | 21 | |||||
A2-3 | 3 | 14 | 10 | 0 | 21 | |||||
A2-4 | 2 | 0 | 11 | 58 | 0 | |||||
A2-5 | 11 | 0 | 14 | 172 | 4 | |||||
A2-6 | 0 | 91 | 76 | 145 | 13 | |||||
A2-7 | 132 | 0 | 0 | 37 | 0 | |||||
A2-8 | 15 | 0 | 0 | 165 | 0 | |||||
Total Responses | 5/8 | 3/8 | 6/8 | 6/8 | 3/8 |
A. HLA-A2-presented EphA2 peptides . | . | . | . | . | . | |||||
---|---|---|---|---|---|---|---|---|---|---|
Normal donor # . | CD8+ T-cell response to peptide on T2.DR4a (IFN-γ spots/105 CD8+ T cells) . | . | . | . | . | |||||
. | 162 . | 391 . | 546 . | 883 . | 961 . | |||||
A2-1 | 9 | 0b | 31 | 0 | 2 | |||||
A2-2 | 40 | 81 | 14 | 85 | 21 | |||||
A2-3 | 3 | 14 | 10 | 0 | 21 | |||||
A2-4 | 2 | 0 | 11 | 58 | 0 | |||||
A2-5 | 11 | 0 | 14 | 172 | 4 | |||||
A2-6 | 0 | 91 | 76 | 145 | 13 | |||||
A2-7 | 132 | 0 | 0 | 37 | 0 | |||||
A2-8 | 15 | 0 | 0 | 165 | 0 | |||||
Total Responses | 5/8 | 3/8 | 6/8 | 6/8 | 3/8 |
B. HLA-DR4-presented EphA2 peptides . | . | . | . | |||
---|---|---|---|---|---|---|
Normal donor # . | CD4+ T-cell response to peptide on T2.DR4a (IFN-γ spots/105 CD4+ T cells) . | . | . | |||
. | 53 . | 63 . | 663 . | |||
DR4-1 | 43 | 11 | 21 | |||
DR4-2 | 38 | 36 | 57 | |||
DR4-3 | 4 | 7 | 14 | |||
DR4-4 | 0 | 0 | 0 | |||
DR4-5 | 0 | 156 | 41 | |||
DR4-6 | 0 | 121 | 67 | |||
DR4-7 | 54 | 48 | 72 | |||
Total Responses | 3/7 | 6/7 | 6/7 |
B. HLA-DR4-presented EphA2 peptides . | . | . | . | |||
---|---|---|---|---|---|---|
Normal donor # . | CD4+ T-cell response to peptide on T2.DR4a (IFN-γ spots/105 CD4+ T cells) . | . | . | |||
. | 53 . | 63 . | 663 . | |||
DR4-1 | 43 | 11 | 21 | |||
DR4-2 | 38 | 36 | 57 | |||
DR4-3 | 4 | 7 | 14 | |||
DR4-4 | 0 | 0 | 0 | |||
DR4-5 | 0 | 156 | 41 | |||
DR4-6 | 0 | 121 | 67 | |||
DR4-7 | 54 | 48 | 72 | |||
Total Responses | 3/7 | 6/7 | 6/7 |